So Yeon Kim, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Genentech
    Topic:
    Ad board
    Date added:
    07/07/2024
    Date updated:
    07/07/2024
    Relationship end date:
    06/26/2026
  • Attribution:
    Other
    Type of financial relationship:
    Contracted Research
    Ineligible company:
    Astrazencea
    Date added:
    07/07/2024
    Date updated:
    07/07/2024
Return to Sept. 27-28, 2024 - Symposium for Evolving Therapies and Drug Development in Oncology